These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27389010)

  • 21. CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).
    Balermpas P; Rödel F; Rödel C; Krause M; Linge A; Lohaus F; Baumann M; Tinhofer I; Budach V; Gkika E; Stuschke M; Avlar M; Grosu AL; Abdollahi A; Debus J; Bayer C; Stangl S; Belka C; Pigorsch S; Multhoff G; Combs SE; Mönnich D; Zips D; Fokas E
    Int J Cancer; 2016 Jan; 138(1):171-81. PubMed ID: 26178914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of CD70 expression on T cells in human T-lymphotropic virus type-1 carriers and adult T cell leukemia/ lymphoma patients.
    Masamoto I; Yoshimitsu M; Kuroki A; Horai S; Ezinne CC; Kozako T; Hachiman M; Kamada Y; Baba M; Arima N
    Leuk Lymphoma; 2016; 57(3):685-91. PubMed ID: 26077361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.
    Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q
    Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of adenosine A2A receptor enhances CD8
    Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy.
    De Schutter H; Landuyt W; Verbeken E; Goethals L; Hermans R; Nuyts S
    BMC Cancer; 2005 Apr; 5():42. PubMed ID: 15847702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD70 is Consistently Expressed in Primary and Metastatic Clear Cell Renal Cell Carcinoma.
    Huang RR; Chen Z; Kroeger N; Pantuck A; Said J; Kluger HM; Shuch B; Ye H
    Clin Genitourin Cancer; 2024 Apr; 22(2):347-353. PubMed ID: 38195301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma.
    Pratt D; Pittaluga S; Palisoc M; Fetsch P; Xi L; Raffeld M; Gilbert MR; Quezado M
    J Neuropathol Exp Neurol; 2017 Aug; 76(8):697-708. PubMed ID: 28789475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
    Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y
    Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of the diagnosis and treatment of cancer located in the head and neck and correlation with expression of prognostic markers.
    Bădulescu F; Bădulescu A; Crişan A; Popescu FC
    Rom J Morphol Embryol; 2013; 54(3):487-97. PubMed ID: 24068395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker.
    Kawakami M; Kawakami K; Kasperbauer JL; Hinkley LL; Tsukuda M; Strome SE; Puri RK
    Clin Cancer Res; 2003 Dec; 9(17):6381-8. PubMed ID: 14695138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD70 in Thymic Squamous Cell Carcinoma: Potential Diagnostic Markers and Immunotherapeutic Targets.
    Kashima J; Hishima T; Okuma Y; Horio H; Ogawa M; Hayashi Y; Horiguchi SI; Motoi T; Ushiku T; Fukayama M
    Front Oncol; 2021; 11():808396. PubMed ID: 35145909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical over expression of p53 in head and neck Squamous cell carcinoma: clinical and prognostic significance.
    Hashmi AA; Hussain ZF; Hashmi SK; Irfan M; Khan EY; Faridi N; Khan A; Edhi MM
    BMC Res Notes; 2018 Jul; 11(1):433. PubMed ID: 29970180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone morphogenetic protein-4-induced epithelial-mesenchymal transition and invasiveness through Smad1-mediated signal pathway in squamous cell carcinoma of the head and neck.
    Xu T; Yu CY; Sun JJ; Liu Y; Wang XW; Pi LM; Tian YQ; Zhang X
    Arch Med Res; 2011 Feb; 42(2):128-37. PubMed ID: 21565626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGFβ1-Smad3-Jagged1-Notch1-Slug signaling pathway takes part in tumorigenesis and progress of tongue squamous cell carcinoma.
    Zhang T; Liang L; Liu X; Wu JN; Chen J; Su K; Zheng Q; Huang H; Liao GQ
    J Oral Pathol Med; 2016 Aug; 45(7):486-93. PubMed ID: 26764364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC).
    Clauditz TS; von Rheinbaben K; Lebok P; Minner S; Tachezy M; Borgmann K; Knecht R; Sauter G; Wilczak W; Blessmann M; Münscher A
    Pathol Res Pract; 2014 Oct; 210(10):649-55. PubMed ID: 25028217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
    Nguyen N; Bellile E; Thomas D; McHugh J; Rozek L; Virani S; Peterson L; Carey TE; Walline H; Moyer J; Spector M; Perim D; Prince M; McLean S; Bradford CR; Taylor JM; Wolf GT;
    Head Neck; 2016 Jul; 38(7):1074-84. PubMed ID: 26879675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implications of hypoxia biomarker expression in head and neck squamous cell carcinoma: a systematic review.
    Swartz JE; Pothen AJ; Stegeman I; Willems SM; Grolman W
    Cancer Med; 2015 Jul; 4(7):1101-16. PubMed ID: 25919147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Over-expression of IQGAP1 indicates poor prognosis in head and neck squamous cell carcinoma.
    Wu CC; Li H; Xiao Y; Yang LL; Chen L; Deng WW; Wu L; Zhang WF; Sun ZJ
    J Mol Histol; 2018 Aug; 49(4):389-398. PubMed ID: 29846864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of Notch1 expression and activation to cisplatin-sensitivity of head and neck squamous cell carcinoma.
    Zhang ZP; Sun YL; Fu L; Gu F; Zhang L; Hao XS
    Ai Zheng; 2009 Feb; 28(2):100-3. PubMed ID: 19550121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of CD45 transcriptional expression in head and neck cancer.
    Camacho M; Agüero A; Sumarroca A; López L; Pavón MÁ; Avilés-Jurado FX; García J; Quer M; León X
    Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):225-232. PubMed ID: 29177949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.